TFA
IART icon

Transamerica Financial Advisors’s Integra LifeSciences IART Stock Holding History

Transamerica Financial Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359 Hold
20
– – ﹤0.01% 1763
2026
Q1 		$188 Buy
+20
New +$220 ﹤0.01% 1645
2025
Q4 		– Sell
-65
Closed -$931 – 1868
2025
Q3 		$931 Buy
+65
New +$890 ﹤0.01% 1181
2013
Q3 		– Sell
-612
Closed -$10K – 611
2013
Q2 		$10K Buy
+612
New +$8.97K ﹤0.01% 424

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Transamerica Financial Advisors's IART Position: Q2 2026 in Review

Transamerica Financial Advisors held its Integra LifeSciences (IART) position steady in Q2 2026 at 20 shares worth $359. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Transamerica Financial Advisors first reported a position in IART in Q2 2013 and has held it in 4 quarters since. The position peaked at $10K in Q2 2013. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Transamerica Financial Advisors held 20 shares of Integra LifeSciences worth $359 as of Q2 2026.
  • Transamerica Financial Advisors left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1763 holding.
  • Transamerica Financial Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 4 quarters since.
  • Transamerica Financial Advisors's Integra LifeSciences position peaked at $10K in Q2 2013.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.